Akèy › Skleroz Amiotrofik Lateral › Kalifòni
Etid klinik pou Skleroz Amiotrofik Lateral nan Kalifòni
23 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- USA004, La Jolla
- USA002, Palo Alto
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Sep 23, 2026 · NCT07290062Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- California Pacific Medical Center, San Francisco
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- University of California San Diego Medical Center, San Diego
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07287397Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Zydus US015, La Jolla
- Zydus US008, Orange
- Zydus US013, San Francisco
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835ASSESS ALL ALS Study
- University of California, Irvine, Irvine
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- ak 1 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- University of California San Diego, La Jolla
- University of California Irvine, Orange
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861Study of COYA 302 for the Treatment of ALS
- Cedars-Sinai Medical Center, Los Angeles
- California Pacific Medical Center, San Francisco
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- University of California, Los Angeles, Los Angeles
- University of California, San Diego, San Diego
- University of California San Francisco, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- University of California San Diego, La Jolla
- Sutter Health - California Pacific Medical Center Research Institute, San Francisco
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 23, 2026 · NCT07142291Clinical Procedures to Support Research in ALS
- University of California, Irvine, Irvine
- Stanford University, Palo Alto
- California Pacific Medical Center, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03489278A Study of Ranolazine in ALS
- University of California, San Francisco, San Francisco
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06527222Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
- Loma Linda University, Loma Linda
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Jun 5, 2026 · NCT04097158Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
- Stanford University School of Medicine, Stanford
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 2, 2026 · NCT05724173BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- University of California, Davis, Sacramento
- Stanford University School of Medicine, Stanford
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 1, 2026 · NCT00912041ALS/MND Natural History Study Data Repository
- Loma Linda University Health, Loma Linda
- Kaiser Permanente, Los Angeles
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou May 20, 2026 · NCT05966038Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
- University of California, Davis, Sacramento
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Apr 14, 2026 · NCT07357428AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
- University of California, San Diego, La Jolla
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06665165Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
- University of California, Davis, Sacramento
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Dec 1, 2025 · NCT06094205Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
- University of California San Diego, San Diego
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05137665Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- University of Southern California, Los Angeles
Ap rekriteFaz 3
Laj 18 a 81 · Tout sèks · Mizajou Sep 12, 2025 · NCT03127267Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- UCSF, San Francisco
- Stanford University, Stanford
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou May 2, 2025 · NCT05395624Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
- Cognixion, Santa Barbara
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2025 · NCT06810219Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.